N. Tamilselvi *, Dona Sara Kurian. Department of Pharmaceutical Analysis. KMCH college of pharmacy Coimbatore
|
|
- Merryl Manning
- 6 years ago
- Views:
Transcription
1 BIOANALYTICAL METHOD DEVELOPMENT AND VALIDATION OF PIRFENIDONE BY RPHPLC METHOD AND ITS APPLICATION TO THE DETERMINATION OF DRUG FOOD INTERACTION STUDY IN WISTER RATS ABSTRACT N. Tamilselvi *, Dona Sara Kurian Department of Pharmaceutical Analysis KMCH college of pharmacy Coimbatore A simple precise, accurate RP-HPLC method has been developed and validated for bioavailability study of pirfenidone in wister rat plasma. The separation and quantization of pirfenidone was achieved on a C18 reversed phase column using the mobile phase in gradient mode constituting of eluant A HPLC grade water (adjusted to ph 3.5) and eluant B 20% acetonitrile and 15% of methanol in the ratio of 60: 40 at a flow rate 1 mlmin -1. Eluted components were detected at 324 nm. The method showed good linearity for Pirfenidone in the range of ng ml -1, Y=54.97x and correlation coefficient R 2 is respectively. The limit of quantitation (LOQ) and limit of detection (LOD) were found to be 12 and 20 ng ml -1 respectively.the developed method shows good accuracy and precision.. Accuracy ranges from 98.49% to 99.37% with the precision 6.43% to 7.67% in inter-day method. Intra-day method the accuracy ranges from 98.64% to 99.33% with the precision 5.64% to 6.93 %. For bioanalytical study, parameters like C max, T max, AUC0-t, AUC 0-, K eli and T 1/2 are compared by statistical analysis. The maximum concentration (C max ) obtained for pirfenidone before and after food was found to be ng ml -1 and 836.5ng ml -1 respectively. The half life (T 1/2 ) of pirfenidone before and after food were calculated and found to be h and h respectively. Area under the curve t AUC. 0 of pirfenidone before food was calculated as nghr ml-1 and t AUC ng ml -1. Area under the curve and AUC was found to be of pirfenidone after food was calculated as nghr ml-1 AUC 0 was found to be ng ml -1. Elimination rate constant for Pirfenidone was found to be h -1 and h -1 respectively. This method was successfully applied to the bioavailability study of pirfenidone. KEYWORDS: Pirfenidone, Tinidazole, RP-HPLC, Rat plasma, Validation INTRODUCTION Pirfenidone is a novel compound with demonstrated anti-inflammatory, anti-fibrotic and antioxidant activities that makes it a suitable candidate molecule for managing idiopathic pulmonary fibrosis[1]. It is the first and only drug which has been approved for the treatment of IPF.Pirfenidone is a small non-peptide molecule of low molecular weight (185.2 daltons). The chemical name is 5-methyl-1-phenyl-2-(1H)-pyridone and its empirical formula is C 12 H 11 NO 2. Pirfenidone inhibits fibroblast proliferation, differentiation and relatedcollagen synthesis. Pirfenidone inhibited the production and activity of TGF-β, a cytokine that stimulatescollagen synthesis and inhibits its degradation. Pirfenidone reduced the production of other mediators of fibrogenesis, such as fibronectin and connective tissue growth factor (CTGF). 0 ISSN : X Vol 3 Issue 3 Jun-Jul
2 Earlier publication have described a method for analysing pirfenidone in biological samples. But this method suffer from some disadvantages, like lack of internal standard, estimation of pirfenidone in rat plasma only under fasting condition. No methods have been reported for the estimation of pirfenidone in rat plasma without fasting, by RP-HPLC method. The aim of this study was to develop a more sensitive liquid chromatographic method for the determination of pirfenidone in rat plasma and the effect of food on its pharmacokinetic profile. MATERIALS AND METHOD Pirfenidone standard was a gift from Cipla Ltd Himachal Pradesh, India. Internal standard used was Tinidazole. Methanol (Finar), Acetonitrile(Rankin), Orthophosphoricacid (SD fine chem), Diethyl ether and Ethyl acetate were of HPLC grade. Water used was HPLC grade and double distilled. Shimadzu LC-20 AT HPLC with UV detector which was set at 324 nm. The analytical column was a C-18 reversed phase column(5µm,25cm 4.6mm ID).The mobile phase consisted of water ph 4.5 (adjusted with orthophosphoric acid) as aqueous phase and Methanol: Acetonitrile (15:20) as organic phase in the ratio 60:40.A flow rate of 1mL/min was used for the sample analysis.the temperature of the column was 25 C. Preparation of standard stock solution Stock solution of pirfenidone and internal standard 1000μg/ml were prepared separately by dissolving 10mg of each drug in 10ml standard flasks and the volume was made up to 10 ml with the mobile phase. From the stock solution, 10μg/ml solution was prepared by diluting 1ml to 100ml with mobile phase. 1ml of the above solution was diluted to 10ml with mobile phase to get a concentration of 1μg/ml. Further solutions were made by from the above solution by diluting 1.0ml, 2.0, 3.0ml, 4.0ml and 5.0ml standard solutions to 10ml in a standard flask with mobile phase to get concentrations of 100,200,300,400 and 500ng/ml respectively. Similarly the working standards were prepared for internal standard also. Sample withdrawal According to the body weight of each animal the drug solution was given through oral gavage. Group (B) animals were kept fasted overnight. Blood samples were withdrawn at specified pre-determined time intervals from 0.5 to 6.0 h, usingretro orbital nerve puncture. The blood samples were immediately transferred to collection tubes containing Disodium EDTA and shaken well, centrifuged using ultra cooling micro centrifuge at 5000 rpm/sec to separate plasma. The separated plasma samples were transferred to a labelled air tight sample tubes and kept in deep freezer for further analysis. Preparation of calibration standard To 200µl of blank plasma,100µl of standard solution of pirfenidone and 100µl of internal standard solutions were added to get concentration of 100, 200, 300, 400 and 500ng/ml respectively. To these calibration standards,100µl of precipitating agent (mixture of ethyl acetate and diethyl ether) was added, and centrifuged for 15 minutes at 5000 rpm. After centrifugation the clear supernatant liquid was collected and kept for evaporation. After complete evaporation the residue was reconstituted with mobile phase. A volume of 20µl was injected into the HPLC column and chromatograms were recorded. Standard calibration graph was plotted using peak area of pirfenidone against its concentration. Method validation The method was validated in terms of accuracy, precision, selectivity, linearity, sensitivity,precision, recovery and stability according to the guidelines issued by the food and drug administration (FDA) for the validation of bioanalytical method. Accuracy and Precision The absolute recovery of pirfenidone was estimated by comparing the response factor of the drug obtained from the plasma with that obtained from the direct injection of drug in mobile phase. The response factor obtained from an amount of the drug added to and extracted from the biological matrix, compare to the response factor obtained for the true concentration of the pure authentic standard is known as the recovery of a drug in an assay.recovery studies were carried out for three levels at six times and the percentage recovery, mean standard deviation and coefficients of variation were calculated. Intraday and interday precision studies were conducted. ISSN : X Vol 3 Issue 3 Jun-Jul
3 The intraday precision was evaluated by analysis of plasma sample containing drug at three different concentration containing the internal standard using nine replicate determinations for three occasion were injected and chromatogram was recorded. The inter -day precision was similarly evaluated over a period of two week and the response factor and RSD were calculated, from that the mean concentration, standard deviation and % CV were calculated. Recovery studies The relative recovery of drug from plasma was calculated by comparing the readings of concentration obtained from the plasma containing drug to that of equal concentration from standard sample. Recovery studies were carried out six times for sample concentration at three levels within the calibration curve. Linearity and range Linearity and range were estimated by using calibration curve. By using calibration standards prepared by spiking drug (pirfenidone) and internal standard (tinidazole) in plasma at different concentrationslike 100ng/ml to 1000ng/ml the calibration graph was plotted taking concentration of spiked plasma on x-axis and peak area on y-axis. The linearity is determined from 50% to 150% of the proposed concentration. Limit of detection and Limit of quantification Using the calibration curve, the LOD and LOQ were determined.limit of quantitation is the concentration of substance in the sample that will give a signal-to-noise ratio of 10:1. Limit of detection is the concentration that will give a signal-to-noise ratio of 3:1. The signal to noise ratio were performed by comparing measured signal of blank plasma sample with those of known low concentration of drug. Stability For a reasonable time, the stability of sample, standard and reagent used in HPLC method is required to generate reproducible and reliable results. Stability of plasma sample spiked with drug were subjected to three freeze-thaw cycles, short term stability at room temperature for 3 hours and long term stability at 20 0 C for four weeks. Stability of standard solution and internal standard were performed at room temperature for 6 hours and under frozen condition for two weeks. The stability of this solution was studied by performing the experiment and looking for change in separation, retention and asymmetry of the peak which were then compared with the pattern of chromatogram of freshly prepared solutions. Selectivity The selectivity was established by two different methods Method I: Chromatograms of six blank plasma samples obtained from six different rats were compared with chromatogram obtained from standard solutions. Interferences due to endogenous plasma component on the retention times of the selected drugs and internal standard were tested. Method ІІ: The peak purity test method using diode array detector is involved in this method. The PDA spectrum, UV spectrum, absorbance ratio curve and first derivative spectrum of the standard and sample peak was recorded using PDA detector and compared for the peak purity of drug. Robustness By changing the chromatographic conditions slightly, the robustness of the method was studied. The standard solutions were injected in these changed chromatographic conditions. ± 1 % difference in the ratio of acetonitrile in the mobile phase. ± 0.5 difference in units of ph of the buffer. ± 1 % difference in flow rate of the mobile phase. In these changed conditions the separation factor, retention time and peak symmetry was calculated. Deviation in results from original run should be less than 2%. System suitability studies In system suitability studies certain parameters such as column efficiency, resolution, capacity factor were calculated, by repeated injection of standard solutions. Capacity factor (k ): It is measurement of sample molecule how good is retained by a column during separation. The ideal k value ranges from Resolution (Rs): It is the difference between the retention times of two solutes divided by their average peak width. The ideal value of (Rs) is 1.5. ISSN : X Vol 3 Issue 3 Jun-Jul
4 Column Efficiency (N): It is measured by the number of theoretical plates per meter. For ideal good separation, column efficiency N value ranging from 5,000 to 100,000 plates/meters. Peak asymmetry factor: For better column performance it was calculated by the formula. When asymmetry factor of value 0.9 to 1.1 then it is achievable for a well packed column. RESULT AND DISCUSSION Chromatographic Conditions Mixture of ethyl acetate and diethyl ether was selected as good separating agent for pirfenidone, since it showed maximum recovery in comparison with acetonitrile and methanol (Table1). The chromatogram was recorded for the standard calibration and plasma sample under developed chromatographic conditions. The retention time of pirfenidone is 6.5 minutes. The chromatogram was well resolved without any interference.peaks not showed any tailing or fronting. The concentration of pirfenidone in rat plasma was determined from the calibration of the spiked plasma by regression analysis. It showed very good linearity in the range of ng/ml and the R 2 value was found to be (fig1) METHOD VALIDATION Accuracy and precision: Accuracy and precision studies were conducted at two levels i.e. intra-day and inter-day. In this present developed method, showed good accuracy and precision. Accuracy ranges from 98.49% to 99.37% with the precision 6.43% to 7.67% in inter-day method. In intra-day method the accuracy ranges from 98.64% to 99.33% with the precision 5.64% to 6.93 %. The data obtained here, was found to be within limits as per ICH guidelines and method was accurate. Intra-day studies: In this plasma concentration of ng/ml were injected six times and mean peak area was calculated separately for each concentration and from that accuracy and precision percentage RSD values were calculated and shown in table 3. Inter-day studies: In this the plasma concentrations of ng/ml were injected into HPLC six times in three different days and mean peak areas were calculated and from that accuracy and precision percentage RSD were calculated and shown in table2. The percentage relative standard deviation of precision for pirfenidone was less than 15% for the bioanalytical study. The results obtained were within limits. Acceptance criteria: The percentage RSD value should be less than 15% for bioanalytical study. Linearity and range : According to ICH guidelines, the method proved to be linear between ng/ml for pirfenidone with a correlation equation Y=54.97x correlation coefficient R 2 was (Fig 1). Limit of Detection and Limit of Quantification: The limit of quantification (LOQ) and limit of detection (LOD) of pirfenidone was found to be 12ng/ml and 20 ng/ml respectively. Recovery from plasma: The extraction efficiency of pirfenidone from rat plasma at the concentrations of 50, 100, and 200 ng/ml was found to be 97.72%, 99.01% and 99.33% with %RSD of 8.2, 7.5, and 7.9. The results of recovery studies are shown in Table 4. Ruggedness: It expresses the precision within laboratories variations like different days, different analyst, and different equipments. Ruggedness of the method was assessed by spiking the standard 6 times in two different days with different analyst and the reports are shown in Table5. System suitability: Column efficiency (theoretical plates), resolution factor and peak asymmetry factor, HETP, tailing factor, LOQ, LOD are the system suitability parameters. These parameters of the optimized methods were found satisfactory. The results of the system suitability studies in plasma were shown in table 6. These parameters were shown to be within specified limits. ISSN : X Vol 3 Issue 3 Jun-Jul
5 Pharmacokinetic Study After a single oral dose of 30.0mg/kg of pirfenidone sample was in measurable amount in plasma up to 0.5 to 2 hours. The pharmacokinetic parameters of the samples were calculated using semilog graph, graph pad version 5, Microsoft excels software and the results were given in the Table 7 and 8. The maximum concentration (C max ) obtained for pirfenidone before food and after food were found to be and ng/ml respectively. The half life (t 1/2 ) of pirfenidone before food and after food were t calculated and found to be h and h. Area under the curve AUC. 0 of pirfenidone before food and after food were found to be and ng h/ml and AUC 0 was found to be and ng h/ml.. Elimination rate constant (k eli ) was calculated for pirfenidone from the slope of log concentration versus time curve with regression analysis. Elimination rate constant for pirfenidone before food and after food were found to be and h -1. The pharmacokinetic parameters such as Cmax, Tmax, AUC 0-t, AUC 0-, K Eli, andt 1/2 were compared by statistical analysis. The p value obtained from t-test was found to be Hence there is no significant difference between the plasma concentration before and after food. Table 1 Recovery study for extraction method Level Conc. Of drug added (ng/ml) Amt. of drug recovered from plasma (ng/ml) % Recovery ACN Methanol Diethyl ether and ethyl acetate mixture ACN Methanol Diethyl ether and ethyl acetate mixture Level I Level II 100 s Level III ISSN : X Vol 3 Issue 3 Jun-Jul
6 Calibration curve PEAK AREA y = x R² = Series1 Linear (Series1) CONCENTRATION ( ng/ml) Fig 1Calibration curve forpirfenidone Table 2 Accuracy and Precision Studies of pirfenidone (Inter day) Si.No Conc. of Drug (ng/ml) Mean* Peak Area Accuracy (%) Precision (%) *n = 6 (Mean of 6 values) for inter day studies ISSN : X Vol 3 Issue 3 Jun-Jul
7 Table 3 Accuracy and Precision Studies of pirfenidone (Intra day) Si.No Conc. of Drug (ng/ml) Mean* Peak Area Accuracy (%) Precision (%) *n = 6 (Mean of 6 values) for intraday studies Table 4 Recovery studies of pirfenidone Levels Conc. of Drug added Amount of drug Relative Recovery % RSD (ng/ml) recovered in plasma (%) sample (ng/ml) Level-I Level-II Level-III ISSN : X Vol 3 Issue 3 Jun-Jul
8 Table5 Ruggedness studies for pirfenidone Drug Concentration Mean * peak area %RSD Pirfenidone 100 ng/ml Day I Analyst 1 Pirfenidone 100ng/ml Day II Analyst 2 *n=6 (Mean of 6 values) Table 6 System suitability studies Si.No Parameters Pirfenidone 1. Theoretical Plate Tailing Factor HETP LOD 12ng/ml 5. LOQ 20ng/ml 6. Resolution K ISSN : X Vol 3 Issue 3 Jun-Jul
9 Table7 Plasma concentration of pirfenidone with food and without food Plasma Concentration( ng/ml) Time (h) Before Food After Food Fig 2 Representative chromatogram of pirfenidone and tinidazole in plasma ISSN : X Vol 3 Issue 3 Jun-Jul
10 Table8 Pharmacokinetic parameters of pirfenidone Pirfenidone Si.No Parameters Before food After food 1 AUC 0-t (ng.h/ml) AUC 0- (ng.h/ml) C max (ng/ml) Tmax (h) K Eli (h -1 ) t 1/2 (h) Concentration (ng/ml) BEFORE FOOD AFTER FOOD Time (hrs) 6 8 Fig 3 Comparison of plasma concentration of Pirfenidone before and after food ISSN : X Vol 3 Issue 3 Jun-Jul
11 CONCLUSION The RPHPLC method developed for the determination of pirfenidone in rat plasma and the effect of food on its pharmacokinetic profile, based on protein precipitation, proved to be rapid and sensitive. Moreover the devised method fully meets FDA guidelines and has high sensitivity, reproducibility and specificity. ACKNOWLEDGEMENTS This work was supported by KMCH college of Pharmacy. REFERENCE [1] Wang Y, Zhao X, Zhong J, Chen Y, Liu X, Wang G.,Biomed.2006, 20:1375. [2] Zhan Xiao-ling, MA Feng-yu1,ZONG Guo-jun2, Anhuai Medical and pharmaceutical journal 2009,15,25. [3] Eur J Pharmacol.2008,590, [4] IDrugs. 2004, 7, [5] Westlake W.J, Peace K, Marcel Dekker, Bioavailability and Bioequivalence of Pharmaceutical Formulations Biopharmaceutical Statistics for Drug Development [6] Guidance for industry Food effect bioavailability and fed bioequivalence studies. US Department of health and humanservices Food and Drug Administration Centre for Drug Evaluation and Research (CDER), December [7] Guidance for industry Bioavailability and Fed bioequivalence studies for orally administered Drug products- General considerations US Department of health and humanservices Food and Drug Administration Centre for Drug Evaluation and Research (CDER), March [8] Guidance for industry: Bioanalytical method validation.us Department of health and humanservices Food and Drug Administration Centre for Drug Evaluation and Research (CDER), Centre for biologics evaluation and Research (CBER),May [9] ICH,Q2 (R1)Validation of Analytical Procedures: Text and Methodology. International Conference on Harmonization of Technical Requirements For Registration of Pharmaceuticals, ICH Harmonized Tripartite guideline November ISSN : X Vol 3 Issue 3 Jun-Jul
A Simple Rapid and Sensitive Method Development for Quantification of Quetiapine Fumarate in Bulk and Dosage Forms Using RP-HPLC
Human Journals Research Article February 2018 Vol.:11, Issue:3 All rights are reserved by Priyanka Teepoju et al. A Simple Rapid and Sensitive Method Development for Quantification of Quetiapine Fumarate
More information10. Validated Normal Phase HPLC Method for the Determination. Fulvestrant is primarily used in the treatment of hormone receptor
229 10. Validated Normal Phase HPLC Method for the Determination of Fulvestrant in Pharmaceutical Dosage Forms 10.1 Introduction Fulvestrant is primarily used in the treatment of hormone receptor positive
More informationValidation of Analytical Methods used for the Characterization, Physicochemical and Functional Analysis and of Biopharmaceuticals.
Validation of Analytical Methods used for the Characterization, Physicochemical and Functional Analysis and of Biopharmaceuticals. 1 Analytical Method Validation: 1..1 Philosophy: Method validation is
More informationISSN India; g,secunderabad. Abstractt. a flow rate. of 1ml/min. di hydrogen. which acts. and chronic. including minimize (5) Figure
B.Lakshmi et al SPJTS,2013,1(1),015-023 RP-HPLC METHOD FOR THE QUANTIFICATION OF ROFLUMILAST IN FORMULATIONS ISSN 2321-4597 B..Lakshmi 1, Prof. T.V.Reddy 2 1.Kallam Haranadha Reddy Institute of Technology,NH-5,
More informationDevelopment and Validation of Isoniazid in Bulk and Pharmaceutical Dosage Forms by UFLC Method
DOI:10.21276/ijprhs.2019.01.09 Shailendra et al. CODEN (USA)-IJPRUR, e-issn: 2348-6465 International Journal of Pharma Research and Health Sciences Available online at www.pharmahealthsciences.net Original
More informationP. Wadhwani College of Pharmacy, Yavatmal , India. *Corres.author: Cell No
International Journal of PharmTech Research CODEN (USA): IJPRIF ISSN : 0974-4304 Vol.6, No.2, pp 512-517, April-June 2014 Validated high performance liquid chromatographic method for determination of Rasagiline
More informationInternational Journal of ChemTech Research CODEN (USA): IJCRGG, ISSN: , ISSN(Online): Vol.10 No.6, pp , 2017
International Journal of ChemTech Research CODEN (USA): IJCRGG, ISSN: 0974-4290, ISSN(Online):2455-9555 Vol.10 No.6, pp 1073-1082, 2017 Cost Effective Stabilty Indicating Reverse Phase High Performance
More informationValidated Stability-indicating assay method for determination of Ilaprazole in bulk drug and tablets by high performance liquid chromatography
Validated Stability-indicating assay method for determination of Ilaprazole in bulk drug and tablets by high performance liquid chromatography Pradeep G. Shelke a*, Anil V. Chandewar a, Anil P. Dewani
More informationLakshmana Rao et.al Indian Journal of Research in Pharmacy and Biotechnology ISSN: (Print) ISSN: (Online)
Development and validation of a stability indicating HPLC method for analysis of Altretamine in bulk drug and pharmaceutical formulations M. Karimulla Santhosh, A. Sreedevi, L. Kalyani, A. Lakshmana Rao
More informationUsharani Gundala* 1, Chandrashekar Bonagiri 2, Devanna Nayakanti 3
IOSR Journal Of Pharmacy (e)-issn: 2250-3013, (p)-issn: 2319-4219 www.iosrphr.org Volume 4, Issue 6 (June 2014), PP. 33-38 Simultaneous Estimation of Paracetamol and Tapentadol in Bulk and Pharmaceutical
More informationInternational Journal of Pharma Research and Health Sciences. Available online at
DOI:10.21276/ijprhs.2016.05.16 G Pratap et al. CODEN (USA)-IJPRUR, e-issn: 2348-6465 International Journal of Pharma Research and Health Sciences Available online at www.pharmahealthsciences.net Original
More informationValidation of a concentration assay using Biacore C
GE Healthcare Application Note 48 Biacore systems Validation of a concentration assay using Biacore C Guideline for development of a GxP - compliant concentration assay Support for informed decision-making
More informationInternational Journal of Institutional Pharmacy and Life Sciences 6(5): September-October 2016
International Journal of Institutional Pharmacy and Life Sciences 6(5): September-October 2016 INTERNATIONAL JOURNAL OF INSTITUTIONAL PHARMACY AND LIFE SCIENCES Pharmaceutical Sciences Research Article!!!
More informationGUIDANCE NOTES ON ANALYTICAL METHOD VALIDATION
ON ANALYTICAL METHOD VALIDATION HSA September 2004 Reproduction prohibited for commercial purposes. Reproduction for internal use is authorised, provided the source is acknowledged. MQA Dir: DISK1\GUIDE-MQA-012A-004.doc
More informationRP-HPLC Method for the Simultaneous Estimation of Lamivudine and Abacavir Sulphate in Tablet Dosage Form
RP-HPLC Method for the Simultaneous Estimation of and Abacavir Sulphate in Tablet Dosage Form T.Sudha, 1* V.R.Ravikumar 2 P.V. Hemalatha 2 1.* Department Of Pharmaceutical Analysis 2. Department Of Pharmacognosy,
More informationJournal of Pharmaceutical and Bioanalytical Science
Journal of Pharmaceutical and Bioanalytical Science Research Article Stability-Indicating RP-HPLC Method for Estimation of Erdosteine and its Degradation Products in Pharmaceutical Dosage Form Anita P.
More informationImpurity Control in the European Pharmacopoeia
Impurity Control in the European Pharmacopoeia Training Session Zagreb, Croatia, 24-25 May, 2018 Dr Ulrich Rose Head of Division European Pharmacopoeia Department, EDQM Agenda Which impurities are controlled?
More informationSIMPLE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY METHOD FOR DETERMINATION OF NORFLOXACIN IN PLASMA AND APPLICATION IN BIOEQUIVALENCE STUDY
Academic Sciences International Journal of Pharmacy and Pharmaceutical Sciences ISSN- 0975-1491 Vol 4, Issue 3, 2012 Research Article SIMPLE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY METHOD FOR DETERMINATION
More informationINTERNATIONAL RESEARCH JOURNAL OF PHARMACY
INTERNATIONAL RESEARCH JOURNAL OF PHARMACY www.irjponline.com ISSN 2230 8407 Research Article RP-HPLC METHOD DEVELOPMENT AND VALIDATION OF DOXAZOSIN FOR THE PRESENCE OF DEGRADATION PRODUCTS AND RELATED
More informationSize Exclusion Chromatography of Biosimilar and Innovator Insulin Using the Agilent AdvanceBio SEC column
Size Exclusion Chromatography of Biosimilar and Innovator Insulin Using the Agilent AdvanceBio SEC column Application Note Bio-Pharmaceutical Authors M. Sundaram Palaniswamy and Andrew Coffey Agilent Technologies,
More informationInternational Journal of Research and Reviews in Pharmacy and Applied science.
International Journal of Research and Reviews in Pharmacy and Applied science www.ijrrpas.com Corresponding Author B.Lakshmi 1, Prof.K.Saraswathi 2, Prof. T.V.Reddy 3 1Kallam Haranadha Reddy Institute
More informationValidation of a Dual Wavelength Size Exclusion HPLC Method with Improved Sensitivity to Detect Aggregates of a Monoclonal Antibody Biotherapeutic
Validation of a Dual Wavelength Size Exclusion HPLC Method with Improved Sensitivity to Detect Aggregates of a Monoclonal Antibody Biotherapeutic By J. Tompkins1, T. Spurgeon 1, R. Tobias 1, J. Anders1,
More informationValidation of Analytical Method of Irbesartan Plasma in Vitro by High Performance Liquid Chromatography-Fluorescence
Journal of Life Sciences 6 (2012) 726-731 Validation of Analytical Method of Irbesartan Plasma in Vitro by High Performance Liquid Chromatography-Fluorescence Harmita, Yahdiana Harahap and I. Kadek Arya
More informationInternational Journal of Pharmacy
International Journal of Pharmacy Journal Homepage: http://www.pharmascholars.com Research Article CDEN: IJPNL6 PLASMA PRTEIN BINDING STUDY F METAXALNE WITH HUMAN PLASMA BY RP-HPLC Kasture Veena S, Mhaske
More informationá1225ñ VALIDATION OF COMPENDIAL PROCEDURES
1640 á1224ñ Transfer of Analytical Procedures / General Information USP 39 THE ANALYTICAL PROCEDURE The procedure should be written with sufficient detail and explicit instructions, so that a trained analyst
More informationVALIDATION OF ANALYTICAL PROCEDURES: METHODOLOGY *)
VALIDATION OF ANALYTICAL PROCEDURES: METHODOLOGY *) Guideline Title Validation of Analytical Procedures: Methodology Legislative basis Directive 75/318/EEC as amended Date of first adoption December 1996
More informationICH Q2(R1) A Primer. cgmp. GxP PIC/S SOP ISO QA/QC LOD/LOQ. Validation of Analytical Methods API EP FDA OECD GCP
USP ICH Q2(R1) A Primer GxP cgmp PIC/S SOP ISO 17025 QA/QC LOD/LOQ API EP Validation of Analytical Methods FDA OECD GCP Validation of Analytical Methods Ludwig Huber Contents Preface...............................................
More informationDEVELOPMENT AND VALIDATION OF ANALYTICAL METHOD FOR ASSAY DETERMINATION OF ISOSULFAN BLUE BY LIQUID CHROMATOGRAPHY
DEVELOPMENT AND VALIDATION OF ANALYTICAL METHOD FOR ASSAY DETERMINATION OF ISOSULFAN BLUE BY LIQUID CHROMATOGRAPHY KISHORKUMAR L.MULE 1 Department of Chemistry, Shri Jagdish Prasad Jhabarmal Tibrewala
More informationSaudi Journal of Medical and Pharmaceutical Sciences
Saudi Journal of Medical and Pharmaceutical Sciences Scholars Middle East Publishers Dubai, United Arab Emirates Website: http://scholarsmepub.com/ ISSN 2413-4929 (Print) ISSN 2413-4910 (Online) Development
More informationRP-HPLC METHOD FOR QUANTITATIVE ESTIMATION OF GLATIRAMER ACETATE FOR INJECTION IN PHARMACEUTICAL DOSAGE FORMS
RP-HPLC METHOD FOR QUANTITATIVE ESTIMATION OF GLATIRAMER ACETATE FOR INJECTION IN PHARMACEUTICAL DOSAGE FORMS ABSTRACT A simple RP-HPLC method for the determination of Glatiramer acetate in pharmaceutical
More informationGuidance for Industry
Guidance for Industry Bioanalytical Methods Validation for Human Studies DRAFT GUIDANCE This guidance document is being distributed for comment purposes only. Comments and suggestions regarding this draft
More informationDevelopment and validation of stability indicating RP-HPLC method for the estimation of Daclatasvir in bulk and formulation
Available online at www.scholarsresearchlibrary.com Scholars Research Library Der Pharmacia Lettre, 2016, 8 (15):107-113 (http://scholarsresearchlibrary.com/archive.html) ISSN 0975-5071 USA CODEN: DPLEB4
More informationResearch Paper Development of Stability Indicating Reverse Phase HPLC Method for Aripiprazole from Solid Dosage form
International Journal of Pharmaceutical Sciences and Nanotechnology 572 International Journal of Pharmaceutical Sciences and Nanotechnology Volume 2 Issue 2 July - September 2009 Volume 2 Issue 2 July
More informationApplication Note. Author. Abstract. Pharmaceuticals. Detlef Wilhelm ANATOX GmbH & Co. KG. Fuerstenwalde, Germany mau
Development, validation, and comparison of an HPLC method to analyze paracetamol and related impurities according to the European Pharmacopoeia (EP) and USP using the Agilent 1120 Compact LC and the Agilent
More informationQuantitative determination of residual 2-(2-chloroethoxy) ethanol (CEE) in quetiapine fumarate by gas chromatogaraphy
Advances in Bioscience and Biotechnology, 2010, 1, 367-371 doi:10.4236/abb.2010.15049 Published Online December 2010 (http://www.scirp.org/journal/abb/). Quantitative determination of residual 2-(2-chloroethoxy)
More informationRESEARCH ARTICLE STABILITY INDICATING ANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR THE ESTIMATION OF AVANAFIL IN PHARMACEUTICAL DOSAGE FORM
RESEARCH ARTICLE ISSN: 2348-8948 Vol: 3; Issue: 6 STABILITY INDICATING ANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR THE ESTIMATION OF AVANAFIL IN PHARMACEUTICAL DOSAGE FORM Bhatt Bhumik, Raval Kashyap,
More informationAnalytical Method Development and Validation for the Estimation of Abiraterone and its Impurity in Pharmaceutical Formulation By RP-HPLC
Available online at www.scholarsresearchlibrary.com Scholars Research Library Der Pharmacia Lettre, 2018, 10 [9]: 19-31 [http://scholarsresearchlibrary.com/archive.html] ISSN 0975-5071 USA CODEN: DPLEB4
More informationIntercontinental journal of pharmaceutical Investigations and Research
Available online at ISSN: 2349-5448 Intercontinental journal of pharmaceutical Investigations and Research ICJPIR Volume 4 Issue 1 Jan Mar- 2017 Research Article A new analytical method development and
More informationAnalytical Method of Limit Test for Hexachlorobenzene. in Picloram TC and Method Validation Data*
Analytical Method of Limit Test for Hexachlorobenzene in Picloram TC and Method Validation Data* Test Method (ABCTM-2010-01-07) 1. Apparatus Electronic Balance GC/MS System with NCI Ultrasonic Water Bath
More informationQuality-by-Design-Based Method Development Using an Agilent 1290 Infinity II LC
Quality-by-Design-Based Method Development Using an Agilent 129 Infinity II LC An Efficient Method Development Workflow Combined with ISET-mediated Method Transfer Under Waters Empower 3 CDS Control Application
More informationEvaluation by Competent Authorities
LANXESS Deutschland GmbH Chlorophene 07/2007 ACTIVE SUBSTANCE RESIDUES IN ANIMAL AND HUMAN BODY FLUIDS AND TISSUES JUSTIFICATION FOR NON-SUBMISSION OF DATA Official use only Other existing data [ ] Technically
More informationVICH Topic GL2 (Validation: Methodology) GUIDELINE ON VALIDATION OF ANALYTICAL PROCEDURES: METHODOLOGY
The European Agency for the Evaluation of Medicinal Products Veterinary Medicines Evaluation Unit CVMP/VICH/591/98-FINAL London, 10 December 1998 VICH Topic GL2 (Validation: Methodology) Step 7 Consensus
More informationBioanalytical method validation: An updated review
Review Article www.phmethods.org Bioanalytical method validation: An updated review Abstract The development of sound bioanalytical method(s) is of paramount importance during the process of drug discovery
More informationA Sub-picogram Quantification Method for Desmopressin in Plasma using the AB SCIEX Triple Quad 6500 System
A Sub-picogram Quantification Method for Desmopressin in Plasma using the AB SCIEX Triple Quad 6500 System A high-throughput method for detecting ultra-low levels (0.5 pg/ml) of a therapeutic peptide in
More informationTHESIS SUBMITTED TO THE ANDHRA UNIVERSITY IN PARTIAL FULFILMENT FOR THE AWARD OF THE DEGREE OF DOCTOR OF PHILOSOPHY IN PHARMACEUTICAL SCIENCES
Synopsis of the Thesis entitled QUANTITATIVE DETERMINATION OF ACTIVE PHARMACEUTICAL INGREDIENTS, RELATED SUBSTANCES AND ORGANIC & POLYMORPHIC IMPURITIES IN PHARMACEUTICAL FORMULATIONS BY LIQUID CHROMATOGRAPHY
More informationANALYSIS OF PESTICIDE RESIDUES IN DRINKING WATER AS PER BUREAU OF INDIAN STANDARDS USING THE AGILENT 7000 GC/MS/MS WITH PESTICIDES ANALYZER
ENVIRONMENTAL ANALYSIS ANALYSIS OF PESTICIDE RESIDUES IN DRINKING WATER AS PER BUREAU OF INDIAN STANDARDS USING THE AGILENT 7000 GC/MS/MS WITH PESTICIDES ANALYZER Solutions for Your Analytical Business
More informationResearch Article Validation of a Statistically Optimized Stability Indicating Method for the Estimation of Febuxostat in a Solid Dosage Form
Cronicon OPEN ACCESS PHARMACEUTICAL SCIENCE Research Article Validation of a Statistically Optimized Stability Indicating Method for the Estimation of Febuxostat in a Solid Dosage Abdul M Ansari 1, Atul
More informationAgreed by VICH Steering Committee January Adoption by CVMP 12 February Date for coming into effect January 2016
12 February 2015 EMA/CVMP/VICH/463202/2009 Committee for Medicinal Products for Veterinary Use (CVMP) VICH topic GL49: Studies to evaluate the metabolism and residues kinetics of veterinary drugs in human
More informationAsian Journal of Research in Chemistry and Pharmaceutical Sciences Journal home page:
Research Article ISSN: 2349 7106 Asian Journal of Research in Chemistry and Pharmaceutical Sciences Journal home page: www.ajrcps.com ANALYTICAL METHOD DEVELOPMENT AND VALIDATION OF PALIPERIDONE IN BULK
More informationCHAPTER-3. Zolmitriptan
45 CHAPTER-3 Zolmitriptan 46 CHAPTER-3 Chapter-3 : Zolmitriptan S. No. Name of the Sub- Title Page No. 3.1 Introduction 47-49 3.2 Experimental 49-59 3.3 Method validation 59-62 3.4 Result& Discussion 62-78
More informationA validated stability indicating HPTLC method for determination of nitazoxanide
Journal of Scientific & Industrial Research Vol. 66, February 2007, pp. 141-145 A validated stability indicating HPTLC method for determination of nitazoxanide C L Gopu, Shibu Thomas, A R Paradkar and
More informationRevision of 30 April 2013 draft, 4 November 2013
GUIDANCE DOCUMENT FOR SINGLE LABORATORY VALIDATION OF QUANTITATIVE ANALYTICAL METHODS USED IN SUPPORT OF PRE- AND POST-REGISTRATION DATA REQUIREMENTS FOR PLANT PROTECTION AND BIOCIDAL PRODUCTS INTRODUCTION
More informationVICH Topic GL49. at step 4 GUIDELINES FOR THE VALIDATION OF ANALYTICAL METHODS USED IN RESIDUE DEPLETION STUDIES
European Medicines Agency Veterinary Medicines and Inspections London, 14 December 2009 Doc. Ref. EMEA/CVMP/VICH/463202/2009-CONSULTATION VICH Topic GL49 at step 4 GUIDELINES FOR THE VALIDATION OF ANALYTICAL
More informationGenotoxicity is the property of a compound
Impurities Analysis in Pharmaceuticals: Genotoxicity is the property of a compound known to have irreversible effects on the structure and functionality of the DNA in cells and cause DNA loss, DNA replication
More informationDevelopment of Difference Spectroscopic Method for the Estimation of Tapentadol Hydrochloride in Bulk and in Formulation
International Journal of PharmTech Research CODEN (USA): IJPRIF ISSN : 0974-4304 Vol.4, No.4, pp 1586-1590, Oct-Dec 2012 Development of Difference Spectroscopic Method for the Estimation of Tapentadol
More informationResearch Article Development and Validation of Acyclovir HPLC External Standard Method in Human Plasma: Application to Pharmacokinetic Studies
Advances in Pharmaceutics, Article ID 284652, 5 pages http://dx.doi.org/10.1155/2014/284652 Research Article Development and Validation of Acyclovir HPLC External Standard Method in Human Plasma: Application
More informationA Rapid Method for Trace Analysis of Organophosphorus Pesticides in Drinking Water
A Rapid Method for Trace Analysis of Organophosphorus Pesticides in Drinking Water Application Note Environmental Authors Min Cai and Yun Zou Agilent Technologies Co. Ltd, 412 Ying Lun Road Waigaoqiao
More informationCHAPTERS 1, 2 and 3 CHAPTER-4 CHAPTER-5,
319 Presently in the pharmaceutical industry, drug analysis plays a vital role in deciding the quality and potency of the drug. The selection of analytical method used to quantify the drugs and impurities
More informationTEMPLATE FOR AN EXAMPLE METHODS VALIDATION STANDARD OPERATING PROCEDURE (SOP)
APPENDIX II TEMPLATE FOR AN EXAMPLE METHODS VALIDATION STANDARD OPERATING PROCEDURE (SOP) SOP EXAMPLE TEMPLATE 1. PURPOSE 1.1 This procedure is intended to provide general guidelines for the validation
More informationTNF (Pig) ELISA Kit. Catalog Number KA assays Version: 05. Intended for research use only.
TNF (Pig) ELISA Kit Catalog Number KA1823 96 assays Version: 05 Intended for research use only www.abnova.com Table of Contents Introduction... 3 Intended Use... 3 Principle of the Assay... 3 General Information...
More informationQuantitatitive Analysis of Phosphorothioate Oligonucleotide in Human Plasma Using LC-MS/MS with On-Line Extraction
Laixin Wang, Sherry Liu, Qiuying Zhu, Scott Reuschel and Min Meng Tandem Labs Quantitatitive Analysis of Phosphorothioate Oligonucleotide in Human Plasma Using LC-MS/MS with On-Line Extraction Introduction
More informationMETHOD FOR SIMULTANEOUS DETERMINATION OF FOLPET AND CYMOXANIL ACTIVE INGREDIENTS (COMBINATION PRODUCTS) IN AQUEOUS MEDIA
METHOD FOR SIMULTANEOUS DETERMINATION OF FOLPET AND CYMOXANIL ACTIVE INGREDIENTS (COMBINATION PRODUCTS) IN AQUEOUS MEDIA Author : S.Y. Pandey and Arun Raithatha Jai Research Foundation Valvada, Gujarat,
More informationDIDANOSINE ORAL POWDER Final text for addition to The International Pharmacopoeia
Document QAS/06.175(A)FINAL August 2007 DIDANOSINE ORAL POWDER Final text for addition to The International Pharmacopoeia This monograph was adopted at the 41 st WHO Expert Committee on Specifications
More informationIAJPS 2017, 4 (07), P. Hari Sravanth Reddy et al ISSN
CODEN [USA]: IAJPBB ISSN: 2349-7750 INDO AMERICAN JOURNAL OF PHARMACEU TICAL SCIENCES http://doi.org/10.5281/zenodo.837292 Available online at: http://www.iajps.com Research Article METHOD DEVELOPMENT
More informationHigh Throughput Quantitation of Cytokine Biomarkers using LANCE Ultra TR-FRET Assays
APPLIATION NOTE LANE TR-FRET Authors: Jen arlstrom Stephen Hurt Roger osse PerkinElmer, Inc. Hopkinton, MA High Throughput Quantitation of ytokine iomarkers using LANE Ultra TR-FRET Assays Introduction
More informationA Sub-picogram Quantification Method for Desmopressin in Plasma using the SCIEX Triple Quad 6500 System
A Sub-picogram Quantification Method for Desmopressin in Plasma using the SCIEX Triple Quad 6500 System A high-throughput method for detecting ultra-low levels (0.5 pg/ml) of a therapeutic peptide in human
More informationA TFC MS/MS Method for the Determination of the Cholinesterase Sensitive Analyte Rivastigmine in Human Plasma
White Paper A TFC MS/MS Method for the Determination of the Cholinesterase Sensitive Analyte Rivastigmine in Human Plasma Lars Neudert, MSc, Senior Scientist Method Development Laurence Meunier, PhD, Senior
More informationPPS (Human) ELISA Kit
PPS (Human) ELISA Kit Cat. No.:DEIA4080 Pkg.Size:96T Intended use Immunoassay for quantitative determination of the content of Pentosan Polysulfate (PPS) in human plasma General Description Pentosan Polysulfate
More informationAvailable Online through (or) IJPBS Volume 2 Issue 3 JULY-SEPT Research Article Pharmaceutical Sciences
Page1 Research Article Pharmaceutical Sciences RP-HPLC DETERMINATION OF RELATED SUBSTANCES OF TAPENTADOL IN BULK AND PHARMACEUTICAL DOSAGE FORM EDIGA SASI KIRAN GOUD* 1, V.KRISHNA REDDY 2 * 1,2 Department
More informationHigh-throughput and Sensitive Size Exclusion Chromatography (SEC) of Biologics Using Agilent AdvanceBio SEC Columns
High-throughput and Sensitive Size Exclusion Chromatography (SEC) of Biologics Using Agilent AdvanceBio SEC Columns Agilent AdvanceBio SEC 3 Å, 2.7 µm columns Application note Bio-Pharmaceutical Author
More informationPerformance characteristics of the 1260 Infinity Quaternary LC system
Performance characteristics of the 1260 Infinity Quaternary LC system The new standard in HPLC Technical Overview Introduction The Agilent 1260 Infinity LC system consists of modular units that operate
More informationInternational Journal of Pharma Research & Review, Feb 2014; 3(2):11-16 ISSN:
Research Article Determination of Methyl Methanesulfonate, Ethyl Methanesulfonate and Isopropyl Methanesulfonate Impurities in Lopinavir API by GC/MS/MS using Electron Ionization Veenaeesh P, *Manikumar
More informationCORESTA RECOMMENDED METHOD N 61
CORESTA RECOMMENDED METHOD N 61 DETERMINATION OF 1,2-PROPYLENE GLYCOL, GLYCEROL AND SORBITOL IN TOBACCO AND TOBACCO PRODUCTS BY HIGH PERFORMANCE LIQUID CHROMATOGRAPHY (HPLC) (July 2015) 0. INTRODUCTION
More informationEAG.COM MATERIALS SCIENCES APPLICATION NOTE. By J. Tompkins 1, T. Spurgeon 1, R. Tobias 1, J. Anders 1, E. Butler-Roberts 2, and M.
MATERIALS SCIENCES NOW WHETHER THE LINER IS THE PROBLEM? HOW DO YOU EVALUATE HYDROPHOBIC COMPOUNDS BY SPME? HOW DO YOU COMPARE FEEDSTOCK SUPPLIERS? O YOU COMPLY WITH ? HOW DO YOU ADDRESS AN
More informationHydroxyproline ELISA Kit
Hydroxyproline ELISA Kit Cat.No: DEIA3605 Lot. No. (See product label) Size 96T Intended use For the quantitative measurement of Hydroxyproline in serum, plasma, tissue homogenates, cell culture supernatants
More informationShort Communication Stability Indicating Assay Method Development and Validation of Tolteridone Tartrate in Bulk Drug and Capsules
Cronicon OPEN ACCESS PHARMACEUTICAL SCIENCE Short Communication Stability Indicating Assay Method Development and Validation of Tolteridone Tartrate in Bulk Drug and Capsules V Asha Ranjani 1 *, T Prabhakar
More informationPHARMA SCIENCE MONITOR ANALYTICAL METHOD DEVELOPMENT OF NUTRACEUTICAL: UMBELLIFERONE
PHARMA SCIENCE MONITOR AN INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES ANALYTICAL METHOD DEVELOPMENT OF NUTRACEUTICAL: UMBELLIFERONE Anuj Malik * 1, Ashok Kushnoor 2, Vipin Saini 1, Sarita Singhal
More informationDevelopment & Validation of RP-HPLC Method for Estimation of Dabigatran Etexilate Mesylate from Capsule Dosage Form
Development & Validation of RP-HPLC Method for Estimation of Dabigatran Etexilate Mesylate from Capsule Dosage Form Bhavna Patel 1,Shoumik Roy 1,Hardik Ghelani 2, Shraddha Parmar 1 * 1 Post Graduation
More informationValidation Report 19
EURL for Cereals and Feeding stuff National Food Institute Technical University of Denmark Validation Report 19 Determination of pesticide residues in oat, rye and wheat by GC-MS/MS and LC-MS/MS (QuEChERS
More informationNISTmAb characterization with a high-performance RP chromatography column
APPLICATION NOTE 21848 NISTmAb characterization with a high-performance RP chromatography column Author Xin Zhang Thermo Fisher Scientific, Sunnyvale, CA, USA Keywords MAbPac RP column, inter-column reproducibility,
More informationBIOEQUIVALENCE TRIAL INFORMATION FORM (Medicines and Allied Substances Act [No. 3] of 2013 Part V Section 39)
ZAMRA BTIF BIOEQUIVALENCE TRIAL INFORMATION FORM (Medicines and Allied Substances Act [No. 3] of 2013 Part V Section 39) The Guidelines on Bioequivalence Studies to be consulted in completing this form.
More informationCHAPTER 7 DETERMINATION OF RELATED SUBSTANCES OF NICORANDIL IN TABLET DOSAGE FORM BY USING REVERSE PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY
DETERMINATION OF RELATED SUBSTANCES OF NICORANDIL IN TABLET DOSAGE FORM BY USING REVERSE PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY CHAPTER 7 Determination of related substances of Nicorandil in tablet
More informationInternational Journal of Applied Pharmaceutical Sciences and Research
International Journal of Applied Pharmaceutical Sciences and Research 2017; 2(2):25-31 Anas et al/international Journal of Applied Pharmaceutical Sciences and Research 2017; 2(2):25-31 International Journal
More informationMicroflow Liquid Chromatography Mass Spectrometry System. Nexera Mikros C146-E350
Microflow Liquid Chromatography Mass Spectrometry System Nexera Mikros C146-E35 Micro: Above and Beyond Nano The High Sensitivity You Expect from a Low Flow System with the Ruggedness of HPLC Covering
More informationDetermination of organochlorine pesticide residues in eggs by gel-permeation chromatography (GPC) cleanup and GC-ECD
Determination of organochlorine pesticide residues in eggs by gel-permeation chromatography (GPC) cleanup and GC-ECD 1. Experimental Section LabTech, Inc. 1.1 Instruments and reagents AutoClean automatic
More informationCCL1 (Human) ELISA Kit
CCL1 (Human) ELISA Kit Catalog Number KA1725 96 assays Version: 04 Intended for research use only www.abnova.com Table of Contents Introduction... 3 Principle of the Assay... 3 General Information... 4
More informationJigar Mehta, Yauvan Pancholi, Vipul Patel, Nayan Kshatri, Niranjan Vyas*
International Journal of PharmTech Research CODEN (USA): IJPRIF ISSN : 0974-4304 Vol.2, No.3, pp 1932-1942, July-Sept 2010 Development and Validation of a Sensitive Stability Indicating Method for Quantification
More informationRayBio Mouse Insulin ELISA Kit
RayBio Mouse Insulin ELISA Kit Catalog #: ELM-Insulin User Manual Last revised April 15, 2016 Caution: Extraordinarily useful information enclosed ISO 13485 Certified 3607 Parkway Lane, Suite 100 Norcross,
More informationEUROPEAN COMMISSION Directorate General Health and Consumer Protection. SANCO/3030/99 rev.4 11/07/00
EUROPEAN COMMISSION Directorate General Health and Consumer Protection SANCO/3030/99 rev.4 11/07/00 Technical Material and Preparations: Guidance for generating and reporting methods of analysis in support
More informationCHAPTER 2 A New stability Indicating RP-HPLC method for related substances in Zolmitriptan
CHAPTER 2 A New stability Indicating RP-HPLC method for related substances in Zolmitriptan Chapter-2 Page 68 2.1. INTRODUCTION This chapter deals the method development and validation of new stability
More informationJournal of Pharmaceutical and Biomedical Analysis Letters. Analysis Letters
N. Usha et al, JPBMAL, 2016, 4(1): 41 50 CODEN (UA): JPBAC9 IN: 2347-4742 Journal of Pharmaceutical and Biomedical Letters Journal Home Page: www.pharmaresearchlibrary.com/jpbmal Research Article Open
More informationAnalysis of amoxicillin and five impurities on the Agilent 1220 Infinity LC System
Analysis of amoxicillin and five impurities on the Agilent Infinity LC System LC analysis of impurities down to the.% level with long sub--µm columns, high flow rates and back pressure greater than bar
More informationDeveloping Robust and Efficient IEX Methods for Charge Variant Analysis of Biotherapeutics Using ACQUITY UPLC H-Class System and Auto Blend Plus
Developing Robust and Efficient IEX Methods for Charge Variant Analysis of Biotherapeutics Using ACQUITY UPLC H-Class System and Auto Blend Plus Robert Birdsall, Thomas Wheat, and Weibin Chen Waters Corporation,
More informationValidated Stability Indicating RP-hplc Method for the Assay of Dienogest in Bulk and Tablet Dosage Form
Available online on www.ijpqa.com International Journal of Pharmaceutical Quality Assurance; 4(2); 20-26 Research Article ISSN 0975 9506 Validated Stability Indicating RP-hplc Method for the Assay of Dienogest
More information